← FDA Drug Approvals (Drugs@FDA)

KETOROLAC TROMETHAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-06-20

Drug application

FDA Application #

ANDA217166

Application type

Abbreviated New Drug Application (Generic)

Brand name

KETOROLAC TROMETHAMINE

Generic name

KETOROLAC TROMETHAMINE

Active ingredients

KETOROLAC TROMETHAMINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ASPIRO

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2023-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown